Continued value of the serum alpha-fetoprotein test in surveilling at-risk populations for hepatocellular carcinoma.
Backgrounds and aimsBecause of the known limitations of ultrasonography (US) alone, we re-evaluated whether complimentary testing for serum alpha-fetoprotein (AFP) is helpful in surveilling for hepatocellular carcinoma (HCC) in high-risk populations.MethodsWe included, from a hospital-based cancer registry, 1,776 asymptomatic adults who were survei